Work

Targeted anti-inflammatory systemic therapy for restenosis: The Biorest Liposomal Alendronate with Stenting sTudy (BLAST)—a double blind, randomized clinical trial

Year: 2012

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: American Heart Journal

DOI: 10.1016/j.ahj.2012.10.023

Authors: Shmuel Banai, Ariel Finkelstein, Yaron Almagor, Abid Assali, Yonathan Hasin, Uri Rosenschein, Patricia Apruzzese, Alexandra J. Lansky, Teruyoshi Kume, Elazer R. Edelman

Institutions: Tel Aviv Sourasky Medical Center, Shaare Zedek Medical Center, Bikur Cholim Hospital, Rabin Medical Center, Poriya Medical Center, Bnai Zion Medical Center, Harvard University, Baim Institute for Clinical Research, Cardiovascular Research Foundation, Stanford Medicine, Harvard–MIT Division of Health Sciences and Technology

Language: English

Topic: Coronary Interventions and Diagnostics

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funder: National Institute of General Medical Sciences

Award: Endovascular Devices and Vascular Repair

OpenAlex ID: W1981270382

FWCI: 2.179

Cites: 23

Cited by: 31

Related to: 10